Clínica Baviera, S.A. (BME:CBAV)

Market Cap	800.93M +43.1%
Revenue (ttm)	304.91M +14.7%
Net Income	42.06M +4.6%
EPS	2.58 +2.7%
Shares Out	16.02M
PE Ratio	19.38
Forward PE	n/a
Dividend	1.57 (3.17%)
Ex-Dividend Date	Jun 11, 2025

Volume	1,991
Average Volume	3,165
Open	50.00
Previous Close	49.50
Day's Range	49.70 - 50.60
52-Week Range	29.70 - 56.60
Beta	0.68
RSI	44.74
Earnings Date	Feb 26, 2026

About Clínica Baviera

Clínica Baviera, S.A., a medical company, operates a network of ophthalmology clinics in Spain and Europe. The company is involved in the diagnosis, treatment, and monitoring of various types of visual disorders. Its clinics offers myopia, hyperopia, astigmatism, farsightedness, presbyopia, cataract, retinal, plastic surgery, pediatric ophthalmology, glaucoma, strabismus, cornea, neuro-ophthalmology, tear ducts, oculoplasty, lasik, and intraocular lenses treatments. The company was formerly known as Clínica Oftalmológica Baviera, S.L. and chang...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1992
• Employees: 1,847
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: CBAV

Financial Performance

In 2025, Clínica Baviera's revenue was 304.91 million, an increase of 14.75% compared to the previous year's 265.72 million. Earnings were 42.06 million, an increase of 4.62%.